ストックスクリーナーアプリを入手
0.905
0.28%
-0.0065
前日終値:
$0.8985
開ける：
$0.909
24時間の取引高:
10,010
Relative Volume:
0.11
時価総額：
$3.73M
収益：
-
当期純損益:
$-3.12M
株価収益率:
-0.188
EPS:
-4.8149
ネットキャッシュフロー:
$-2.69M
1週間 パフォーマンス:
+5.16%
1か月 パフォーマンス:
-20.71%
6か月 パフォーマンス:
-81.97%
1年 パフォーマンス:
-50.77%
1日の値動き範囲:
$0.8302
$0.91
1週間の範囲:
$0.7983
$0.9365
52週間の値動き範囲:
$0.6578
$17.75
180 Life Sciences Corp Stock (ATNF) Company Profile
ATNF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATNF
180 Life Sciences Corp
|
0.905 | 3.73M | 0 | -3.12M | -2.69M | -4.8149 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.09 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
559.01 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
594.73 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.31 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.84 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-09-15 | 開始されました | Maxim Group | Buy |
180 Life Sciences Corp (ATNF) 最新ニュース
Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter
ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire
180 Life Sciences Corp. SEC 10-K Report - TradingView
ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Increases By 67.2% - Defense World
180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World
Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generation Therapies - openPR
180 Life Sciences (NASDAQ:ATNF) Given Sell (E+) Rating at Weiss Ratings - Defense World
180 Degree Capital (NASDAQ:TURN) Given Sell (D-) Rating at Weiss Ratings - Defense World
Synergy CHC (SNYR) Projected to Post Earnings on Monday - Defense World
Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drug - The Economic Times
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Up 29.3% in February - Defense World
Janone Inc. (NASDAQ:ALTS) Short Interest Up 40.9% in February - Defense World
180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Growth in Short Interest - Armenian Reporter
ATNF stock touches 52-week low at $1.1 amid market fluctuations - Investing.com
Contract wins and repeat business fuel progress at life sciences company - The Business Desk
180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Down 50.4% in February - Defense World
Short Interest in ArrowMark Financial Corp. (NASDAQ:BANX) Expands By 62.6% - Defense World
American Rebel Holdings, Inc. (NASDAQ:AREB) Sees Large Growth in Short Interest - Defense World
ATNF stock touches 52-week low at $1.14 amid market shifts - Investing.com India
Global Dupuytrens Disease Market Deep Research 2025-2032 | Endo - openPR
180 Life Sciences Appoints New Chief Accounting Officer - TipRanks
180 Life Sciences (NASDAQ:ATNF) Receives Sell (E+) Rating from Weiss Ratings - Armenian Reporter
180 Life Sciences (NASDAQ:ATNF) Given “Sell (E+)” Rating at Weiss Ratings - Defense World
TURN180 Degree Capital Corp Latest Stock News & Market Updates - StockTitan
180 Life Sciences Corp. modifies former CEO's exit terms - MSN
180 Life Sciences Corp. modifies former CEO’s exit terms By Investing.com - Investing.com India
180 Life Sciences Corp. modifies former CEO's exit terms By Investing.com - Investing.com Canada
180 Life Sciences Appoints New CEO Amid Leadership Changes - TipRanks
Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan
180 Life Sciences (NASDAQ:ATNF) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World
Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y - Yahoo Finance
Sai Life Sciences Shares Continue To Decline, Slumps Over 11% In A Week Despite Expansion Plans - Free Press Journal
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration - ACCESS Newswire
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules - ACCESS Newswire
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why - Nasdaq
180 Life Sciences Corp (ATNF) 財務データ
収益
当期純利益
現金流量
EPS
0.77%
0.11%
大文字化:
|
ボリューム (24 時間):